Publication | Closed Access

Identification of NF-κB inhibitors following Shenfu injection and bioactivity-integrated UPLC/Q-TOF-MS and screening for related anti-inflammatory targets in vitro and in silico

InflammationSystems PharmacologyRelated Anti-inflammatory TargetsAnti-inflammatoryMedicineImmune RegulationImmunologyShenfu InjectionImmune SurveillanceInnate ImmunityImmune FunctionImmune SystemPharmacologyInflammatory DiseaseDrug DiscoveryNf-κb Inhibitors